We are live on ! Find out more
TTP

TITAN PHARMACEUTICAL INC
TTP

Delisted

TTP was delisted on the 24th of December, 2008.

1 hedge funds and large institutions have $4K invested in TITAN PHARMACEUTICAL INC in 2017 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 (0)

0% more capital invested

Capital invested by funds: $4K → $4K ($0)

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
VIA
1
Vantage Investment Advisors
Pennsylvania
$4K

TTP Hedge Fund Activity: Q3 2017 in Review

1 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q3 2017, worth a combined $4K — unchanged from a quarter earlier.

Fund positioning in TTP was balanced in Q3 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held TITAN PHARMACEUTICAL INC (TTP) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $4K of TITAN PHARMACEUTICAL INC stock for Q3 2017, unchanged quarter-over-quarter.
  • 0 funds opened new TITAN PHARMACEUTICAL INC positions in Q3 2017 and 0 closed out.

Based on aggregated 13F filings for Q3 2017.